Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
EARLY_PHASE1
20
about 4.2 years
18+
1 site in CA
What this study is about
This trial is testing whether oral ketamine or a placebo can help reduce anxiety in people with pancreatic cancer. The goal is to see if it's possible to enroll enough patients and have them follow the treatment plan. Researchers will also look at safety, tolerability, and how ketamine/placebo affects anxiety symptoms and other health measures.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Ketamine
- 2.Take Placebo
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
ketamine (NMDA receptor antagonist; induces dissociative anesthesia and analgesia)
Secondary: To investigate the safety of oral ketamine in patients with pancreatic cancer and anxiety, which will be assessed by the number of adverse events related to study treatment per CTCAE v.5., To investigate the tolerability of oral ketamine in patients with pancreatic cancer and anxiety, which will be measured by patient-reported Ketamine Adverse Symptom Checklist and Impact scores.
Psychiatry / Mental Health, Oncology